Lisa Phillips is an experienced Healthcare M&A Expert, B2B writer, research analyst, and journalist. She joined Irving Levin Associates in December 2012 as Editor of The Health Care Information Source and all its companion products, the weekly Health Care Deal News, the monthly Health Care M&A News, the quarterly Health Care M&A Report and annual Health Care Services Acquisition Report.
Lisa has more than 25 years of reporting, writing and researching content for trade publications such as Advertising Age, American Demographics, The American Lawyer and Folio:. She helped to launch a new line of business research at Gartner, Inc., as Editorial Director of GartnerG2. Her previous position was as a Senior Analyst at eMarketer, Inc.
Read Full Bio
PTC Therapeutics, Inc. (NASDAQ: PTCT) jumped into competition with BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) with its acquisition of Censa Pharmaceuticals, Inc. Censa has developed CNSA-001 (sepiapterin), a clinical-stage investigational therapy for orphan metabolic... Read More »
Correlation doesn’t prove causation, but the evidence is hard to ignore. April healthcare M&A took a hit as COVID-19 forced businesses to close, workers to stay home, and providers to divert all their attention toward treating the flood of infected patients.... Read More »
Deal making is getting more creative in the time of COVID-19. Mednax, Inc. (NYSE: MD) sold its anesthesiology group, American Anesthesiology, Inc., to North American Partners in Anesthesia (NAPA), a portfolio company of American Securities, for $50 million. In an 8k... Read More »
At the start of the year, the biggest disruption expected in the Home Health & Hospice sector was the Patient-Driven Groupings Model (PDGM), a reimbursement overhaul introduced by the Centers for Medicare and Medicaid Services (CMS) on January 1, 2020. The impact... Read More »
Even as it scrambles to join the hunt for a COVID-19 vaccine, Pfizer Inc. (NYSE: PFE) is still open to other ventures. On April 30 the Big Pharma signed a collaboration agreement with French specialty vaccine maker Valneva SE to develop and commercialize... Read More »